2-AMINO-N-(2,3-DIHYDRO-8-(3-((2-HYDROXYETHYL)AMINO)PROPOXY)-7-METHOXYIMIDAZO(1,2-C)QUINAZOLIN-5-YL)-5-PYRIMIDINECARBOXAMIDE
UNII QYB71X85N4
Substance Identification & Data
This profile provides standardized clinical and technical data for 2-amino-n-(2,3-dihydro-8-(3-((2-hydroxyethyl)amino)propoxy)-7-methoxyimidazo(1,2-c)quinazolin-5-yl)-5-pyrimidinecarboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QYB71X85N4.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2132943-81-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H26N8O4 MRKSMBKRMJMBJR-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2-amino-n-(2,3-dihydro-8-(3-((2-hydroxyethyl)amino)propoxy)-7-methoxyimidazo(1,2-c)quinazolin-5-yl)-5-pyrimidinecarboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.